ICYMI: THE NEW YORK TIMES EDITORIAL BOARD ENDORSES SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by… Read More
Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by… Read More
Decision Appropriately Balances Access to Treatment with the Need for More… Read More
New Report Demonstrates How Brand Name Drug Companies Work in “Lockstep”… Read More
Academic Study Underscores How Big Pharma’s Price-Gouging on Treatments for… Read More
Lawmakers Double-Down on Repeated Promises to the American People to Lower… Read More
Congress Can Refocus Attention on Market-Based Solutions to Crack Down on… Read More
Non-Profit and Private Sector Partners Work Together to Help Provide Relief… Read More
Matrix Global Advisors Report Further Undermines Big Pharma’s Supply Chain… Read More
Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable… Read More
KFF Analysis Shows Big Pharma’s Price Hikes Outpaced Inflation for Half of… Read More
New Earnings Reports Show Big Pharma Giants Continue to Reap Massive Profits,… Read More
FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting… Read More